eXoZymes, Inc. EXOZ
Set alert
4.32 USD -0.03 -0.69%
As of Nov 3, 9:34 AM ET
4.32 Day range 4.32
3.24 52-week range 18.40
- YTD
- -60.37%
- 1 year
- -68.05%
- Open
- 4.32
- Prev close
- 4.35
- Mkt cap
- 40.20M
- Vol
- 557
- Avg vol
- 8.36K
- EPS
- -1.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.32
- High
- 4.32
1Y chart
Signals (33)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 5 days ago |
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| RSI: Oversold | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| RSI: Oversold | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bearish | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| RSI: Overbought | Apr 6, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| RSI: Oversold | Mar 2, 2026 | 8 months ago |
Newest 20 of 33.
Financials — quick view
EXOZ Revenue — quarterly 0
EXOZ Net income — quarterly -2.88M
EXOZ EPS — quarterly -0.33
News
- eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research
- Water Tower Research Publishes Initiation of Coverage Report on eXoZymes, Inc., "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity"
- Head to Head Contrast: Iovance Biotherapeutics (NASDAQ:IOVA) vs. eXoZymes (NASDAQ:EXOZ)
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
- eXoZymes Q2 Earnings Call Highlights
- eXoZymes Q2 Earnings Call Highlights
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
- eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
Your note
Sign in to keep a note on EXOZ — it syncs with the Stock Master app.